Source: International Congress 2016 – Molecular targets in pulmonary disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Tanya Tacheva (Stara Zagora, Bulgaria), Tanya Tacheva, Dimo Dimov, Yoana Georgieva, Vanya Ilieva, Atanas Koychev, Tatyana Vlaykova. Plasma levels of TIPM-2 in patients with COPD. Eur Respir J 2016; 48: Suppl. 60, 883

Member's Comments

No comment yet.

Related content which might interest you: Plasma surfactant protein D (SP-D) and smoking status in patients with COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Serum BNP levels in COPD, asthma-COPD-overlap-syndrome, smokers and never-smokers Source: International Congress 2016 – Systemic biomarkers Year: 2016 MMP2 -1306C>T polymorphism and the enzyme plasma levels in patients with COPD Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Cytokines and MMP-9 level in serum and induced sputum of patients with suspicion of occupational COPD Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods Year: 2016 Serum levels of leptin and visfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Different data in COPD Year: 2015 Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 The effect of smoking on the activity of inflammatory markers in patients with COPD Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease Year: 2013 Plasma surfactant protein D (SP-D) and comorbidity rate in patients with COPD Source: International Congress 2014 – Predictors Year: 2014 Serum leptin, adponectin and its tissue expression in COPD patients with osteopenic syndrome Source: International Congress 2015 – COPD: notable points Year: 2015 MMP-3 serum levels and MMP3 -1171insA promoter polymorphism in patients with COPD Source: International Congress 2014 – Basic and translational research in asthma and COPD Year: 2014 Serum levels of RAAS components in COPD Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Serum IL-17 and IL-18 levels in asthma-COPD overlap syndrome patients Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 Sputum levels of miR-145 and miR-338 in COPD, asthma and ACOS subjects Source: International Congress 2016 – Mechanisms of disease Year: 2016 Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory Source: Annual Congress 2013 –COPD treatment Year: 2013 Lung function in never smoking patients with alpha1antitrypsin deficiency Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013 Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Serum levels of a MMP-12 generated type IV collagen fragment is elevated in COPD and IPF patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Serum sirtuin-1 is reduced in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016